Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction and Consolidation Chemotherapy in Locally Advanced Rectal Cancer (RuCorT-03)
NCT04135313Phase 3Unknown
- Sponsor
- N.N. Blokhin Russian Cancer Research Center
- Start
- Oct 2019
- Primary completion
- Oct 2024
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine, oxaliplatin in rectal cancer, sponsored by N.N. Blokhin Russian Cancer Research Center. Status: unknown.
02
Drugs
capecitabineoxaliplatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT04135313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04135313.